期刊文献+

JAKs家族基因在急性髓系白血病中的表达与预后的相关性分析 被引量:1

The expression of JAKs family-gene in acute myeloid leukemia patients and its correlation with the prognosis
下载PDF
导出
摘要 目的:分析JAKs家族基因在不同时期急性髓系白血病(AML)细胞中的表达及其与预后的相关性.分析JAKs家族基因在不同时期急性髓系白血病(AML)细胞中的表达及其与预后的相关性.方法:RT-PCR法分别检测AML初治组、复发组、完全缓解组(CR组)以及正常对照组(NC组)骨髓MNC细胞中JAKs家族基因(JAK1、JAK2、JAK3和TYK2 mRNA)的表达.同时对初治组患者随访3年,统计3年生存率.结果:初治组和复发组AML患者JAK3和TYK2 mRNA表达水平均高于CR组和NC组(P〈0.05~P〈0.01),4组JAK2 mRNA表达水平差异有统计学意义(P〈0.05),而初治组和复发组以及CR组和NC组间JAKs家族基因表达水平差异无统计学意义(P〉0.05);JAK1、JAK2、JAK3和TYK2阳性组和阴性组间CR率差异无统计学意义(P〉0.05).Kaplan-Meier分析显示,JAK1、JAK2、JAK3 和TYK2 mRNA阳性表达组3 年生存率依次为36.75%、33.12%、22.13%和19.07%,而阴性表达者依次为46.56%、41.25%、39.55%和37.02%.COX 风险回归分析显示,JAK3 和TYK2 mRNA阳性表达是影响AML患者预后的独立危险因素(P〈0.05).结论:JAKs家族基因在AML发生、发展中发挥重要作用,尤其是JAK3和TYK2 mRNA表达阳性与CR和总体生存率关系密切,直接影响预后. Objective:To analyze the expressions of JAKs family-gene in different periods of acute myeloid leukemia( AML) cells,and its correlation with the prognosis of patients. Methods:The mRNA expressions of JAKs family-gene( including JAK1,JAK2,JAK3 and TYK2) in bone marrow MNC of the first-treated group,recurrence group and complete remission group(CR group) and normal control group( NC group) were detected using RT-PCR method. All cases were followed up for 3 years, and the 3-year survival rate was analyzed. Results:The expression levels of the JAK3 and TYK2 mRNA in the first-treated group and recurrence group were higher than those in CR group and NC group(P〈0. 05 to P〈0. 01),the differences of the expression level of the JAK2 mRNA in the 4 groups were were statisticallg significant(P〈0. 05),and the differences of the mRNA expression levels of JAKs family-gene between the first-treated group,recurrence group,CR group and NC group were not statistically significant(P〉0. 05). The differences of the CR rate in the JAK1,JAK2,JAK3 and TYK2 positive group and negative group were not statistically significant(P〉0. 05). Kaplan-Meier analysis showed that the 3-year survival rates in the JAK1,JAK2,JAK3 and TYK2 mRNA positive expression groups were 36. 75%,33. 12%, 22. 13% and 19. 07%,respectively;the 3-year survival rates in the JAK1,JAK2,JAK3 and TYK2 mRNA negative expression groups were 46. 56%,51. 25%,39. 55% and 37. 02%,respectively. COX regression analysis showed that the positive expressions of JAK3 and TYK2 mRNA were the independent risk factors affecting the prognosis of AML patients. Conclusions:JAKs family genes play an important role in the occurrence and development of AML,especially the positive expressions of JAK3 and TYK2 mRNA are closely connected with CR and overall survival,and directly affect the prognosis.
出处 《蚌埠医学院学报》 CAS 2015年第10期1305-1308,共4页 Journal of Bengbu Medical College
关键词 急性髓系白血病 JAKs基因 预后 acute myeloid leukemia JAKs gene prognosis
  • 相关文献

参考文献14

  • 1Li HS, Watowieh SS. Innate immune regulation by STAT-mediated transcriptional mechanisms [ J]. Immunol Rev, 2014,261 ( 1 ) : 84 - 101.
  • 2O'Shea JJ, Schwartz DM, Villarino AV, et al. The JAK-STAT pathway: impact on human disease and therapeutic intervention [J]. Annu Rev Med,2015,14(66) :311 -328.
  • 3Meyer SC, Levine RL. Molecular pathways: molecular basis for sensitivity and resistance to JAK kinase inhibitors [ J ]. Clin Cancer Res,2014 ,20 (8) :2051 - 2059.
  • 4Works MG, Yin F, Yin CC, et al. Inhibition of TYK2 and JAKIameliorates imiquimod-induced psoriasis-like dermatitis by inhibiting IL-22 and the IL-23/IL-17 axis [ J ]. J Immuno, 2014, 193 (7) :3278 - 3287.
  • 5Zheng Y, Qin H, Frank SJ, et al. A CK2-dependent mechanism for activation of the JAK-STAT signaling pathway [ J]. Blood ,2011, 118(1) :156 -166.
  • 6Park MS, Kim BR, Kang S, et al. The antihypertension drug doxazosin suppresses JAIL/STATs phosphorylation and enhances the effects of IFN -c~ induced apoptosis[ J ]. Genes Cancer,2014, 5(11/12) :470 -479.
  • 7Poussin K, Pilati C, Couchy G, et al. Biochemical and functional analyses of gpl30 mutants unveil JAK1 as a novel therapeutic target in human inflammatory hepatocellular adenoma [ J ]. Oncoimmunology ,2013,2 ( 12 ) : e27090.
  • 8Chen P, Zhao D, Sun Y, et al. Protein inhibitor of aetivated STAT- 1 is downregulated in gastric canecr tissue and involved in cell metastasis[ Jl. Oncol Rep,2012,28(6) :2149 -2155.
  • 9张国建,李猛,王天阳,石铖,王晨宇,闫庆辉.去甲斑蝥素通过JAK-STAT3途径诱导结肠癌LS-174T细胞凋亡[J].肿瘤防治研究,2014,41(1):16-21. 被引量:12
  • 10马戎,王海琳,叶云飞,徐立新.AG490单用或联合顺铂对人宫颈癌裸鼠移植瘤STAT3/Survivin信号转导通路的影响[J].中国妇幼保健,2011,26(21):3295-3299. 被引量:1

二级参考文献58

共引文献16

同被引文献45

  • 1蔡良真.木犀草素对人白血病HL-60细胞内蛋白激酶C的抑制作用[J].右江医学,2005,33(2):106-108. 被引量:11
  • 2Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk : an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols [ J ]. J Clin Onco1,2002,20 (3) :776-790.
  • 3Kaya M. Prognostic factors for osteosarcoma patients [ M ]. Chapter: Osteosarcoma, Springer Japan, 2016:73 -79.
  • 4Zhang H, Wu H, Zheng J, et al. Transforming growth factor β1 signal is crucial for dedifferentiation of cancer cells to cancer stem cells in osteosarcoma[ J]. Stem Cells ,2013,31 ( 3 ) :433-446.
  • 5Lee DF, Su J, Kim HS, et al. Model osteosarcoma by Li-Franmeni syndrome patient-specific induced pluripotent stem cells [ J ]. Cancer Res ,2015,75 ( 15 Supplement) :5129-5129.
  • 6Kansara M, Teng MW, Smyth M J, et al. Translational biology of osteosarcoma[ J]. Nat Rev Cancer,2014,14 ( 11 ) :722-735.
  • 7Gongalves C, Martins-Neves SR, Paiva-Oliveira D, et al. Sensitizing osteosarcoma stem ceils to doxorubicin-induced apoptosis through retention of doxorubicin and modulation of apoptotic-related proteins[ J]. Life Sci ,2015,130:47-56.
  • 8Tirino V,Desiderio V,Paino F,et al. Cancer stem cells in solid tumors: overview and new approaches for their isolation and characterization [ J ]. FASEB J, 2013,27 ( 1 ) : 13-24.
  • 9Basu-Roy U, Basilieo C, Mansukhani A. Perspectives on cancer stem cells in osteosarcoma[ J]. Cancer Lett,2013,338 (1) :158-167.
  • 10Jeon YW, Suh YJ. Synergistic apoptotic effect of celecoxib and luteolin on breast cancer cells[J]. Oncol Rep,2013,29(2) :819-825.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部